Sarepta Therapeutics Inc (SRPT)
Activity ratios
Short-term
Turnover ratios
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 1.42 | 1.59 | 2.06 | 2.02 | 2.44 | 2.23 | 1.85 | 1.78 | 1.45 | 1.55 | 1.03 | 1.14 | 1.28 | 1.37 | 1.43 | 1.75 | 1.78 | 1.67 | 1.61 | 1.57 |
| Receivables turnover | 3.70 | 3.08 | 3.47 | 4.24 | 4.36 | 4.28 | 4.35 | 4.10 | 4.30 | 4.59 | 4.31 | 4.71 | 4.85 | 5.33 | 4.06 | 4.33 | 3.81 | 4.19 | 5.37 | 6.05 |
| Payables turnover | 5.79 | 3.11 | 5.70 | 4.17 | 4.63 | 4.74 | 3.46 | 6.59 | 5.34 | 3.75 | 6.70 | 3.99 | 4.00 | 2.87 | 4.21 | 3.43 | 11.57 | 4.20 | 3.28 | 5.59 |
| Working capital turnover | 0.76 | 0.65 | 0.55 | 0.51 | 0.50 | 0.48 | 0.43 | 0.43 | 0.37 | 0.33 | 0.36 | 0.33 | 0.30 | 0.26 | 0.25 | 0.21 | 0.18 | 0.32 | 0.32 | 0.27 |
Sarepta Therapeutics Inc's activity ratios provide insights into how efficiently the company manages its assets and liabilities.
1. Inventory turnover: This ratio measures how many times inventory is sold and replaced over a period. Sarepta's inventory turnover has been fluctuating, indicating some variability in how quickly the company is selling its inventory. The average inventory turnover appears to be around 1.6 times per year, which suggests that the company might need to consider managing its inventory more effectively to improve this ratio.
2. Receivables turnover: This ratio reflects how efficiently a company collects cash from its customers. Sarepta's receivables turnover has shown a consistent pattern of around 4 times per year, indicating that the company is collecting its receivables efficiently.
3. Payables turnover: The payables turnover ratio indicates how quickly a company pays its suppliers. Sarepta's payables turnover has been fluctuating significantly, with an average turnover of approximately 5 times per year. This could suggest that the company's payment practices to suppliers vary quarter to quarter.
4. Working capital turnover: This ratio evaluates how effectively a company utilizes its working capital to generate revenue. Sarepta's working capital turnover has been relatively stable around 0.4 times per year, indicating that the company is efficiently using its working capital to generate sales.
Overall, Sarepta Therapeutics Inc's activity ratios show areas of strength, such as receivables turnover, but also highlight areas that may require attention, like inventory management and payment practices to suppliers. These ratios provide valuable insights for stakeholders assessing the company's operational efficiency and liquidity management.
Average number of days
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 257.17 | 229.52 | 177.52 | 180.87 | 149.88 | 163.73 | 197.05 | 204.98 | 251.69 | 236.11 | 355.90 | 321.02 | 285.83 | 265.80 | 255.91 | 208.79 | 205.34 | 218.98 | 226.17 | 232.22 |
| Days of sales outstanding (DSO) | days | 98.53 | 118.32 | 105.32 | 86.14 | 83.74 | 85.26 | 83.96 | 89.09 | 84.93 | 79.56 | 84.69 | 77.56 | 75.25 | 68.49 | 89.82 | 84.34 | 95.73 | 87.10 | 68.01 | 60.36 |
| Number of days of payables | days | 63.02 | 117.24 | 63.98 | 87.53 | 78.91 | 76.96 | 105.53 | 55.36 | 68.31 | 97.30 | 54.49 | 91.59 | 91.16 | 127.29 | 86.65 | 106.53 | 31.54 | 87.01 | 111.41 | 65.33 |
The Days of Inventory on Hand (DOH) for Sarepta Therapeutics Inc have shown a fluctuating trend over the past several quarters, ranging from 149.88 days to 257.17 days. This indicates that the company has experienced variations in the efficiency of managing its inventory levels. A higher number of days suggests that the company is taking longer to sell its inventory, which may tie up working capital.
The Days of Sales Outstanding (DSO) have also shown variability, with figures fluctuating between 68.49 days and 118.32 days. A lower DSO indicates that the company is collecting its accounts receivable more quickly, which is a positive indicator of the company's liquidity and efficiency in managing its receivables.
The Number of Days of Payables has displayed significant volatility, ranging from 31.54 days to 127.29 days. A lower number of days of payables implies that the company is paying its suppliers more quickly, which may strain its working capital. On the other hand, a higher number of days of payables can indicate that the company is taking advantage of lenient payment terms.
Overall, Sarepta Therapeutics Inc's activity ratios demonstrate fluctuations in its inventory management, accounts receivable collection, and accounts payable practices, which can impact the company's liquidity and overall financial health. Monitoring these ratios over time can provide insights into the company's operational efficiency and working capital management.
Long-term
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | 5.63 | 5.47 | 5.20 | 5.31 | 5.34 | 5.18 | 4.84 | 4.56 | 4.09 | 3.67 | 3.24 | 2.95 | 2.82 | 2.84 | 2.88 | 2.94 | 2.97 | 2.94 | 3.05 | 2.94 |
| Total asset turnover | 0.44 | 0.38 | 0.36 | 0.32 | 0.32 | 0.30 | 0.28 | 0.28 | 0.25 | 0.22 | 0.24 | 0.22 | 0.21 | 0.18 | 0.18 | 0.16 | 0.14 | 0.21 | 0.21 | 0.20 |
Sarepta Therapeutics Inc's long-term activity ratios provide insights into the efficiency with which the company utilizes its assets. The fixed asset turnover ratio has shown a consistent increasing trend over the periods, indicating that the company is generating more sales relative to its investment in fixed assets. This suggests that Sarepta is effectively utilizing its property, plant, and equipment to drive revenue growth.
On the other hand, the total asset turnover ratio depicts a declining trend over the periods. This may indicate that the company is becoming less efficient in generating sales relative to its total assets. A lower total asset turnover ratio could imply that Sarepta's overall asset base is not being fully utilized to generate revenue.
Overall, while Sarepta Therapeutics Inc appears to be efficiently utilizing its fixed assets to drive sales growth, there may be room for improvement in optimizing the utilization of its total assets to enhance overall operational efficiency. Monitoring these ratios over time can provide valuable insights into the company's asset management strategies and operational effectiveness.